N/A
Completed N=223
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Source: ClinicalTrials.gov NCT00966446 ↗
Enrolled (actual)
223
Serious AEs
7.2%
Results posted
Jun 2016
Primary outcomePrimary: Recurrent Infection — 1; 3; 1 participants
Summary
The overall goal of this project is to elucidate the epidemiology of MRSA transmission in the community and test an intervention to prevent MRSA transmission in this setting.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Recurrent Infection |
1; 3; 1 | — |
| PRIMARY First Two Consecutive Sampling Periods Completed |
48; 49; 52 | — |
| SECONDARY Time to Clearance of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization |
23; 23; 19 | — |
Eligibility Criteria
Inclusion Criteria
- All members of a household in which the index case is treated for a skin or soft tissue infection due to MRSA. All household members must agree to participate in order for the household to be enrolled
Exclusion Criteria
- Prior MRSA within past 6 months in the index case; age less than 6 months.
Data sourced from ClinicalTrials.gov (NCT00966446). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.